Hormel Foods reported fiscal 2025 net sales exceeding $12 billion, representing 2% organic growth driven by gains across all three segments, though profitability was severely pressured by over 500 basis points of raw material cost inflation in Q4 and avian illnesses. Adjusted EPS for the year was $1.37, significantly missing goals, with Q4 adjusted EPS at $0.32 and a GAAP loss per share of $0.10 due to impairment charges of $235 million related to international investments and the snack nuts business. Despite these headwinds, the company returned a record $633 million to shareholders and announced a 1% dividend increase. Looking to fiscal 2026, management forecasts organic net sales growth of 1% to 4% and adjusted EPS of $1.43 to $1.51, anticipating margin recovery through pricing actions, mix improvements, and restructuring savings, though Q1 earnings are expected to decline year-over-year.
| Metric | Value | Change |
|---|---|---|
| Net Sales | >$12 Billion | +2% Organic |
| Adjusted EPS (FY25) | $1.37 | Decrease vs prior year |
| Diluted EPS (FY25) | $0.87 | N/A |
| Q4 Adjusted EPS | $0.32 | N/A |
| Q4 Diluted EPS | -$0.10 | N/A |
| Operating Margin | 5.9% | N/A |
| Adjusted Operating Margin | 8.4% | N/A |
| Cash Flow from Operations | $805 Million | N/A |
| Dividend Increase | 1% | To $1.17 annualized |
Management is aggressively repositioning Hormel from a traditional meat company into a 'consumer-focused company that wins with protein.' This involves stretching brands like SPAM into new formats (e.g., sushi-style Musubi) and leveraging Jennie-O for convenient meal solutions. This strategic pivot aims to drive 'mix improvements' and margin expansion by moving up the value chain, capitalizing on the enduring consumer trend for protein-centric convenience.
A significant strategic signal is the 'portfolio reshaping' initiative to simplify operations and focus on high-growth categories. This includes moving the Justin's business into a strategic partnership and exiting non-strategic private label lines. By shedding underperforming or non-core assets, management is freeing up resources to reinvest in 'strategic categories' like SPAM, Planters, and Jennie-O, signaling a more disciplined capital allocation approach.
The company is prioritizing 'future-ready' operational improvements through the 'Transform and Modernize' initiative and the adoption of AI technology. Examples include using generative AI for Skippy marketing and implementing O9 for supply chain planning. This focus on data and technology aims to boost efficiency and support the 'enhanced marketing programs' necessary to defend market share in a strained consumer environment.
Management is taking a more aggressive stance on pricing to combat inflation, implementing 'two waves of pricing actions' in 2025 with more realization expected in 2026. They are also refining their forecasting to be 'real-time responsive' to commodity volatility. This signals a shift towards protecting margins through price realization, even if it risks volume in the short term, as they aim to restore the balance between costs and pricing.
The company recorded substantial non-cash impairment charges of $235 million ($164 million in international, $71 million in retail) related to a minority investment in Indonesia and the snack nuts business. This raises red flags about prior capital allocation decisions and the immediate profitability of the international segment and the Planters recovery, suggesting management may have overpaid for assets or misjudged market conditions.
Guidance for fiscal 2026 indicates a weak start, with management explicitly stating 'we expect Q1 earnings to decline compared to the prior year' by 2-4 cents. This front-loaded weakness, driven by the timing of pricing realization and lingering cost inflation, suggests the recovery path is fragile and heavily back-half loaded, increasing the risk of another earnings miss if commodity costs do not decline as forecasted.
Persistent margin pressure remains a major concern, with Q4 raw material cost inflation exceeding 500 basis points. While management expects pork costs to decline, they anticipate beef and nut costs to remain 'elevated' headwinds throughout 2026. Additionally, the return of HPAI (Highly Pathogenic Avian Influenza) in the turkey supply chain threatens to disrupt production and inflate costs again, posing a risk to the projected margin expansion.
The international segment faced significant headwinds, with the Brazil market described as a 'drag' on performance and trade disruptions impacting profits. The large impairment in Indonesia combined with the struggles in Brazil suggests execution risk in emerging markets, potentially leading to further strategic withdrawals or write-downs as the company reviews its portfolio.
Overall: Management displayed a tone of accountability regarding the 'disappointing' earnings miss but shifted to a determined and optimistic demeanor when discussing the future. They acknowledged the 'challenging' environment candidly but emphasized 'conviction to win' and confidence in their 'protein-centric' strategy. The tone in prepared remarks was apologetic about the past but resolute about the path forward, while the Q&A session was defensive yet transparent as they justified the conservative guidance and restructuring efforts.
Confidence: MEDIUM - Management admitted to falling 'significantly short' and provided a wide guidance range (4-10% operating income growth) for 2026, reflecting uncertainty about commodity costs and the consumer. While confident in brand strength and long-term strategy, their near-term confidence was tempered by the recognition of persistent headwinds like HPAI and inflation.
1% to 4%
4% to 10%
$1.43 to $1.51
Expected decline vs prior year (down 2-4 cents)
Hedging & Uncertainty: Management utilized frequent hedging language to manage expectations regarding the volatile cost environment and consumer demand. Phrases such as 'dynamic environment,' 'expect,' 'anticipate,' and 'wider range' were used to qualify guidance. Specifically regarding the turkey market, John Ghingo stated, 'it's early, and very little is settled at this point,' and Paul Keenan noted they are 'modeling' pork benefits for the second half. This hedging reveals a lack of visibility into near-term commodity deflation and a cautious approach to promising a robust recovery, contrasting with their 'conviction to win' narrative.
Fiscal 2025 was a challenging year. Candidly, we fell significantly short of our earnings goal. - Paul Keenan, Interim Chief Financial Officer
We are the consumer company that wins with protein. - John Ghingo, President
We expect Q1 earnings to decline compared to the prior year... mainly due to the timing of the impacts of pricing. - Jeff Ettinger, Interim Chief Executive Officer
We are actively listening, learning, and anticipating to better understand the challenges and aspirations of our consumers. - John Ghingo, President
We believe we are coming out of fiscal 2025 with a conviction to win. - Paul Keenan, Interim Chief Financial Officer
Analyst Sentiment: Analysts were skeptical and probing, focusing heavily on the mathematical feasibility of the 2026 guidance given the discrete benefits (restructuring, lapping recalls) versus persistent headwinds (inflation). There was a clear demand for transparency on how much of the recovery is cost-driven versus volume-driven.
Management Responses: Management was transparent but defensive, breaking down the 'puts and takes' of the guidance in detail. They emphasized that while Q1 is weak, the back-half recovery is robust. They deflected specific commodity predictions by citing volatility but stood firm on their pricing power and the strategic value of their portfolio reshaping.
Detailed breakdown of the 2026 guidance bridge, specifically the quantification of restructuring savings ($60M gross) and reinvestment plans.
Turkey market dynamics, specifically the impact of HPAI on supply and the pricing assumptions for whole birds versus ground turkey.
The recovery trajectory of the Planters brand, specifically regarding distribution gains and profit margins amidst cashew mix shifts.
Strategic review of the international portfolio, specifically the future of the Brazil venture and the rationale behind the Indonesian impairment.
Hormel Foods is currently in a transition phase, attempting to pivot from a difficult fiscal 2025 characterized by significant inflation and operational missteps to a recovery in 2026. While the 'protein-centric' strategy is sound and brands like SPAM and Jennie-O demonstrate resilience, the guidance implies a slow start to the year with Q1 earnings expected to decline. The reliance on pricing actions in a volume-constrained, value-seeking consumer environment introduces risk, and the recent impairments raise questions about capital allocation history. The 1% dividend hike, while maintaining the 'Aristocrat' status, is underwhelming. Investors should wait for concrete evidence of margin expansion and consistent top-line execution before adding to positions, as the current wide guidance range suggests low visibility.
Management reported over 500 basis points of raw material cost inflation in Q4 alone, driven by pork, beef, and turkey. While pork is expected to decline in H2 2026, beef and nut costs are anticipated to remain elevated headwinds.
Management described the consumer as 'quite strained' and 'value-seeking' due to cumulative inflation effects. They expect this behavior to persist throughout 2026, impacting volume potential.
The broader food service industry experienced traffic declines and did not grow as expected in 2025. Management forecasts only 'flat to little growth' for the industry in 2026.
Avian illnesses (HPAI) returned in Q4, particularly in the Midwest, causing turkey supply constraints that are expected to continue into 2026.